Delivery Order SPE2DB20D1100-SPE2DB25FB9N6
- Not listed
- The Defense Logistics Agency awarded a $2,198.43 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for Lo Loestrin Fe 1-10 tablets in a quantity of 28-unit packages at a firm fixed price of $1,050.53. This non-set-aside competitive award, with an ultimate completion date of October 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28s, a hormonal contraceptive medication. This firm fixed-price delivery order, valued at $1,497.08, represents a non-competitive award and is part of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The order is scheduled for completion by September 16, 2025, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,386.52 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on May 20, 2025, with an ultimate completion date of May 21, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.15 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packages) on September 18, 2025, with completion targeted for September 19, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $4,039.86 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Lo Loestrin Fe 1-10 tablets (quantity: 28-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lo Loestrin FE 1-10 tablets in quantities of 28 tablets per unit, with a contract ceiling value of $1,756.95. This firm fixed price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lo Loestrin FE 1-10 tablets (28-count packaging) with a ceiling value of $3,613.04. This is a firm fixed-price delivery order with an ultimate completion date of June 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FB9N6Delivery Order
The Defense Logistics Agency awarded a $1,075.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for Lo Loestrin Fe 1-10 tablets (28-count packages). This is a competitive award with no set-aside designation, with performance required at the vendor's facility in Conshohocken, Pennsylvania, and an ultimate completion date of April 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceuticals, medical supplies, brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contraceptive medication delivery under this order demonstrates the company's versatility in fulfilling specialized federal medical supply requirements through the flexible IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/25/25 |